The Scientist : Chasing Challenges
The Scientist  

By Andrea Gawrylewski

Chasing Challenges

AstraZeneca's Karen Gotting-Smith is using a newly-created position to tackle some old problems.

In the fall of 2003, Karen Gotting-Smith thought her new job as project leader at AstraZeneca in charge of launching the cholesterol-lowering drug Crestor (rosuvastatin) in the US and global market would be relatively straightforward. After all, Crestor had already been approved in Europe the year before, and just that summer got a nod from a public Food and Drug Administration advisory committee.



For FREE access to this article and more, you must register.

Not yet registered? Get free access
 

The article you are attempting to read is only available to registered users of The Scientist. Registration is FREE and only takes a few seconds.

  
 

Email

Password

> Forgot Password?
> FAQ
> Subscribe
 
Not yet registered? Get free access
 

Create your MyScientist account and access all of The Scientist's free content, tools and life science email newsletters, including:

 

> The current month’s print issue

> Daily & Bi-weekly e-mail newsletters

> Newsblogs with breaking headlines

> The Scientist Community

> Exclusive web extras

> The Scientist Careers

 

Premium content from The Scientist Archive, a comprehensive resource of over 22 years of past life science coverage, is available only by subscription. Subscribe today and get unlimited access